Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna R Mortensen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|October 16, 2019
[Proton therapy]Hanna R Mortensen, Morten Høyer, Cai Grau
Acta Oncologica (Stockholm, Sweden)|November 24, 2012
Aspiration pneumonia in patients treated with radiotherapy for head and neck cancerHanna R Mortensen, Kenneth Jensen, Cai Grau
Ugeskrift for Laeger|February 26, 2019
[Dysphagia]Bahareh B Philipsen, Hanna R Mortensen, Dorte Melgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2013
Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parametersHanna R Mortensen, Kenneth Jensen, Karin Aksglæde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Lena Specht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2015
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinomaNina M Lyhne, Hanne Primdahl, Claus A Kristensen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Kenneth Jensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2025
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancerCamilla Skinnerup Byskov, Hanna R Mortensen, Marie-Claude Biston, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|October 16, 2019
[Proton therapy]Hanna R Mortensen, Morten Høyer, Cai Grau
Acta Oncologica (Stockholm, Sweden)|November 24, 2012
Aspiration pneumonia in patients treated with radiotherapy for head and neck cancerHanna R Mortensen, Kenneth Jensen, Cai Grau
Ugeskrift for Laeger|February 26, 2019
[Dysphagia]Bahareh B Philipsen, Hanna R Mortensen, Dorte Melgaard
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2013
Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parametersHanna R Mortensen, Kenneth Jensen, Karin Aksglæde, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Lena Specht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2015
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinomaNina M Lyhne, Hanne Primdahl, Claus A Kristensen, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2013
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancerHanna R Mortensen, Jens Overgaard, Kenneth Jensen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancerMelissa Thomas, Hanna R Mortensen, Lone Hoffmann, et al.
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2025
Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancerCamilla Skinnerup Byskov, Hanna R Mortensen, Marie-Claude Biston, et al.
Pageof 2